A.R.T. Advisors’s VolitionRx Ltd VNRX Stock Holding History

A.R.T. Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-807	Closed	-$91K	–	1758
2019 Q3	$91K	Buy	+807	New	+$64.2K	﹤0.01%	1271

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return

A.R.T. Advisors's VNRX Position: Q4 2019 in Review

A.R.T. Advisors sold out of VolitionRx Ltd (VNRX) in Q4 2019, closing a stake of 807 shares — an estimated $91K sold.

A.R.T. Advisors first reported a position in VNRX in Q3 2019 and held it in 1 quarter. The position peaked at $91K in Q3 2019. 36 funds tracked by Wall St. Rank hold VNRX as of Q4 2019.

A.R.T. Advisors reported no remaining VolitionRx Ltd position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 807 VolitionRx Ltd shares in Q4 2019, an estimated $91K.
A.R.T. Advisors first reported a position in VolitionRx Ltd in Q3 2019 and held it in 1 quarter.
A.R.T. Advisors's VolitionRx Ltd position peaked at $91K in Q3 2019.
36 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.